GTG 8.33% 3.9¢ genetic technologies limited

Ann: Financing and Restructure Plan Finalised, page-2

  1. 656 Posts.
    lightbulb Created with Sketch. 13
    Focus now on two key areas, Brevagen Plus and Patent Infrigement. New management, cost cutting and a launch in October sets the scene for a new beginning. Ironbridge last loan funds to convert at market less 40% so lets give them something to think about! Once they are out of the way, Brevagen sales and 7 figure Cash settlements for patent breeches will pave the way!
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.003(8.33%)
Mkt cap ! $5.671M
Open High Low Value Volume
3.8¢ 3.9¢ 3.8¢ $68 1.75K

Buyers (Bids)

No. Vol. Price($)
1 24250 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 114500 1
View Market Depth
Last trade - 14.48pm 09/08/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.